XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Statements of Consolidated Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
OPERATING ACTIVITIES      
Net income $ 37,111,000 $ 63,337,000 $ 54,399,000
Adjustments to reconcile net income to net cash provided by operations:      
Depreciation and amortization 20,830,000 18,914,000 16,430,000
Provision for accounts receivable allowances (875,000) 3,441,000 2,169,000
Provision for inventory reserves 4,498,000 8,081,000 2,352,000
Deferred income taxes 1,084,000 (2,232,000) (2,656,000)
Share-based compensation expense 3,412,000 4,948,000 4,596,000
Goodwill impairment 0 0 6,529,000
Gain from company owned life insurance policy 0 0 (4,364,000)
Loss on exit of business 0 0 1,025,000
Gain on sale of property and equipment (1,748,000) (2,478,000) (775,000)
Other, net 828,000 435,000 92,000
Changes in operating assets and liabilities      
Accounts receivable (8,710,000) 16,969,000 (28,049,000)
Inventories 6,784,000 (4,952,000) (36,979,000)
Prepaid expenses (3,988,000) 5,961,000 5,051,000
Trade accounts payable and accrued liabilities 8,602,000 2,302,000 6,707,000
Accrued income and other taxes 590,000 (937,000) 2,005,000
Contributions to company pension plan 0 (1,500,000) (2,132,000)
Other, net (938,000) (4,647,000) (247,000)
NET CASH PROVIDED BY OPERATING ACTIVITIES 67,480,000 107,642,000 26,153,000
INVESTING ACTIVITIES      
Capital expenditures (14,651,000) (35,332,000) (40,598,000)
Proceeds from the sale of property and equipment 3,454,000 2,631,000 3,169,000
Proceeds from sale of investments 1,993,000 0 0
Purchases of investments (3,154,000) 0 0
Proceeds from company owned insurance policy 0 0 6,909,000
Acquisition of businesses, net of cash 0 (12,089,000) (16,235,000)
NET CASH USED IN INVESTING ACTIVITIES (12,358,000) (44,790,000) (46,755,000)
FINANCING ACTIVITIES      
Proceeds (payments) of notes payable to banks 860,000 (11,081,000) 2,214,000
Proceeds from long-term debt 96,410,000 169,172,000 185,016,000
Payments of long-term debt (130,133,000) (186,179,000) (155,929,000)
Dividends paid (4,076,000) (4,106,000) (4,099,000)
Proceeds from issuance of common shares 214,000 2,164,000 808,000
Purchase of common shares for treasury (226,000) (728,000) (158,000)
Purchase of common shares for treasury from related parties (8,379,000) (18,164,000) (5,309,000)
Other (2,473,000) 0 0
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (47,803,000) (48,922,000) 22,543,000
Effects of exchange rate changes on cash, cash equivalents and restricted cash (3,682,000) 2,438,000 (1,108,000)
Net increase in cash, cash equivalents and restricted cash 3,637,000 16,368,000 833,000
Cash, cash equivalents and restricted cash at beginning of year 53,607,000 37,239,000 36,406,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF YEAR $ 57,244,000 $ 53,607,000 $ 37,239,000